Skip to content
MedsAcross

Medicine

Clindamycin and Tretinoin 12 mg/0.25 mg per g gel

Available on requestPrescription onlyUS FDAGeneric name

Clindamycin and Tretinoin 12 mg/0.25 mg per g gel is a generic prescription medicine for topical use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 25°C (77°F), excursions permitted to 15° to 30°C (59° to 86°F). •…

Key facts

Active ingredient (INN)
Clindamycin and Tretinoin
Brand
Sold under the generic name
Strength
12 mg/0.25 mg per g
Dosage form
Gel
Route
Topical
Packs
1 tube and 1 more
Manufacturers
Actavis PharmaOceanside Pharmaceuticals
Origin register
US FDA, United States
Storage
Store at 25°C (77°F), excursions permitted to 15° to 30°C (59° to 86°F). • Protect from light. • Protect from freezing. • Keep out of the reach of children. • Keep away from heat. • Keep tube tightly closed.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
HS code (indicative)
3004.20Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
5 July 2016
Identifiers
RxCUI 882548DailyMed set ID 63b2e85d-8fe5-4f18-9e85-8492c49a7520, 79e1c8f6-59cd-4efa-9efa-0762d4b1a10cNDC 68682-300, 0472-1790Application NDA050802, ANDA202564

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
1 tube in 1 carton / 30 g in 1 tube0472-1790-30Actavis Pharma5 July 2016
1 tube in 1 carton / 60 g in 1 tube0472-1790-60Actavis Pharma5 July 2016
1 tube in 1 carton / 30 g in 1 tube68682-300-30Oceanside Pharmaceuticals4 August 2020
1 tube in 1 carton / 60 g in 1 tube68682-300-60Oceanside Pharmaceuticals4 August 2020

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 7 November 2006Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Clindamycin and Tretinoin 12 mg/0.25 mg per g gel.

Compare 1

Other strengths and forms of Clindamycin and Tretinoin

Clinical summary

Clindamycin and Tretinoin is a fixed-dose combination of a lincosamide antibacterial and a retinoid indicated for the topical treatment of acne vulgaris in patients 12 years or older. MedsAcross supplies Clindamycin and Tretinoin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Clindamycin and Tretinoin

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Clindamycin and Tretinoin 12 mg/0.25 mg per g gel for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.